These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


336 related items for PubMed ID: 34383534

  • 1. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
    Idema IME, Payne JM, Coghill D.
    J Consult Clin Psychol; 2021 Jul; 89(7):615-625. PubMed ID: 34383534
    [Abstract] [Full Text] [Related]

  • 2. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM, Coghill DR, Matthews K.
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [Abstract] [Full Text] [Related]

  • 3. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
    Coghill DR, Rhodes SM, Matthews K.
    Biol Psychiatry; 2007 Nov 01; 62(9):954-62. PubMed ID: 17543895
    [Abstract] [Full Text] [Related]

  • 4. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
    Horowitz I, Avirame K, Naim-Feil J, Rubinson M, Moses E, Gothelf D, Levit-Binnun N.
    Psychiatry Res; 2020 Sep 01; 291():113056. PubMed ID: 32554183
    [Abstract] [Full Text] [Related]

  • 5. Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
    Pearson DA, Santos CW, Aman MG, Arnold LE, Lane DM, Loveland KA, Mansour R, Ward AR, Casat CD, Jerger S, Schachar RJ, Bukstein OG, Cleveland LA.
    J Child Adolesc Psychopharmacol; 2020 Sep 01; 30(7):414-426. PubMed ID: 32644833
    [Abstract] [Full Text] [Related]

  • 6. Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder.
    Bedard AC, Martinussen R, Ickowicz A, Tannock R.
    J Am Acad Child Adolesc Psychiatry; 2004 Mar 01; 43(3):260-8. PubMed ID: 15076258
    [Abstract] [Full Text] [Related]

  • 7. Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.
    Hammerness P, Fried R, Petty C, Meller B, Biederman J.
    Child Neuropsychol; 2014 Mar 01; 20(3):319-27. PubMed ID: 23639146
    [Abstract] [Full Text] [Related]

  • 8. How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition.
    Hawk LW, Fosco WD, Colder CR, Waxmonsky JG, Pelham WE, Rosch KS.
    J Child Psychol Psychiatry; 2018 Dec 01; 59(12):1271-1281. PubMed ID: 29733106
    [Abstract] [Full Text] [Related]

  • 9. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K, Halari R, Mohammad AM, Taylor E, Brammer M.
    Biol Psychiatry; 2011 Aug 01; 70(3):255-62. PubMed ID: 21664605
    [Abstract] [Full Text] [Related]

  • 10. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA, Backenson EM, Wilcox G, Piercy JC, Hale JB.
    Postgrad Med; 2012 Sep 01; 124(5):33-48. PubMed ID: 23095424
    [Abstract] [Full Text] [Related]

  • 11. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD.
    Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP.
    Eur Neuropsychopharmacol; 2021 May 01; 46():1-13. PubMed ID: 33735707
    [Abstract] [Full Text] [Related]

  • 12. Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder.
    Berman T, Douglas VI, Barr RG.
    J Abnorm Psychol; 1999 Feb 01; 108(1):90-105. PubMed ID: 10066996
    [Abstract] [Full Text] [Related]

  • 13. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N, Yechiam E, Carmel Z, Levkovitz Y.
    J Clin Psychopharmacol; 2014 Apr 01; 34(2):261-5. PubMed ID: 24525641
    [Abstract] [Full Text] [Related]

  • 14. Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder.
    Wu CS, Shang CY, Lin HY, Gau SS.
    J Child Adolesc Psychopharmacol; 2021 Apr 01; 31(3):187-196. PubMed ID: 33890819
    [Abstract] [Full Text] [Related]

  • 15. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B, Karakaya E, Oztop DB.
    J Child Adolesc Psychopharmacol; 2015 Aug 01; 25(6):494-500. PubMed ID: 26218871
    [Abstract] [Full Text] [Related]

  • 16. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y, Doniger GM, Barak R, Simon ES, Hausdorff JM.
    J Child Neurol; 2007 Mar 01; 22(3):264-76. PubMed ID: 17621495
    [Abstract] [Full Text] [Related]

  • 17. Effects of methylphenidate on intelligence and attention components in boys with attention-deficit/hyperactivity disorder.
    Hellwig-Brida S, Daseking M, Keller F, Petermann F, Goldbeck L.
    J Child Adolesc Psychopharmacol; 2011 Jun 01; 21(3):245-53. PubMed ID: 21663427
    [Abstract] [Full Text] [Related]

  • 18. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI, Bijlenga D, Boonstra AM, Breuk M, Pardoen WF, Beekman AT, Kooij JJ.
    Eur Neuropsychopharmacol; 2014 Apr 01; 24(4):519-28. PubMed ID: 24508533
    [Abstract] [Full Text] [Related]

  • 19. Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder.
    Rhodes SM, Coghill DR, Matthews K.
    Psychopharmacology (Berl); 2004 Sep 01; 175(3):319-30. PubMed ID: 15138760
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.